BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

730 related articles for article (PubMed ID: 17545869)

  • 1. Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.
    Neff BA; Wiet RM; Lasak JM; Cohen NL; Pillsbury HC; Ramsden RT; Welling DB
    Laryngoscope; 2007 Jun; 117(6):1069-72. PubMed ID: 17545869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML; Breen JT; Driscoll CL; Link MJ; Neff BA; Gifford RH; Beatty CW
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management strategy of vestibular schwannoma in neurofibromatosis type 2.
    Odat HA; Piccirillo E; Sequino G; Taibah A; Sanna M
    Otol Neurotol; 2011 Sep; 32(7):1163-70. PubMed ID: 21817944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing rehabilitation in neurofibromatosis type 2 patients: cochlear versus auditory brainstem implantation.
    Vincenti V; Pasanisi E; Guida M; Di Trapani G; Sanna M
    Audiol Neurootol; 2008; 13(4):273-80. PubMed ID: 18259080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Auditory brainstem implant (ABI): new frontiers in adults and children.
    Colletti V; Carner M; Miorelli V; Guida M; Colletti L; Fiorino F
    Otolaryngol Head Neck Surg; 2005 Jul; 133(1):126-38. PubMed ID: 16025066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Auditory brainstem implant: indications and results].
    Bouccara D; Kalamarides M; Bozorg Grayeli A; Ambert-Dahan E; Rey A; Sterkers O
    Ann Otolaryngol Chir Cervicofac; 2007 Jul; 124(3):148-54. PubMed ID: 17320034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auditory brainstem implants in NF2 patients: results and review of the literature.
    Sanna M; Di Lella F; Guida M; Merkus P
    Otol Neurotol; 2012 Feb; 33(2):154-64. PubMed ID: 22246383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Auditory brainstem implant in neurofibromatosis type 2 and non-neurofibromatosis type 2 patients.
    Grayeli AB; Kalamarides M; Bouccara D; Ambert-Dahan E; Sterkers O
    Otol Neurotol; 2008 Dec; 29(8):1140-6. PubMed ID: 18849886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cochlear implantation in neurofibromatosis type 2 after radiation therapy.
    Trotter MI; Briggs RJ
    Otol Neurotol; 2010 Feb; 31(2):216-9. PubMed ID: 19887974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Morawski K; Niemczyk K; Marchel A
    Neurol Neurochir Pol; 2015; 49(5):295-301. PubMed ID: 26377980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial auditory and cognitive effects of auditory brainstem implantation in children.
    Colletti L
    Acta Otolaryngol; 2007 Sep; 127(9):943-6. PubMed ID: 17712673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cochlear implantation on the management strategy of patients with neurofibromatosis type 2.
    Tan H; Jia H; Li Y; Zhang Z; Zhu W; Cai Y; Wang Z; Wu H
    Eur Arch Otorhinolaryngol; 2018 Nov; 275(11):2667-2674. PubMed ID: 30229456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ipsilateral Cochlear Implantation in the Presence of Observed and Irradiated Vestibular Schwannomas.
    Urban MJ; Moore DM; Kwarta K; Leonetti J; Rajasekhar R; Gluth MB; Wiet RM
    Ann Otol Rhinol Laryngol; 2020 Dec; 129(12):1229-1238. PubMed ID: 32551844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The retrosigmoid approach for auditory brainstem implantation.
    Colletti V; Fiorino FG; Carner M; Giarbini N; Sacchetto L; Cumer G
    Am J Otol; 2000 Nov; 21(6):826-36. PubMed ID: 11078071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear implantation in patients with auditory neuropathy of varied etiologies.
    Mason JC; De Michele A; Stevens C; Ruth RA; Hashisaki GT
    Laryngoscope; 2003 Jan; 113(1):45-9. PubMed ID: 12514381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochlear implants to treat deafness caused by vestibular schwannomas.
    Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
    Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear implantation in patients with substantial residual hearing.
    Cullen RD; Higgins C; Buss E; Clark M; Pillsbury HC; Buchman CA
    Laryngoscope; 2004 Dec; 114(12):2218-23. PubMed ID: 15564849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.